| Literature DB >> 34221838 |
Yoichiro Tohi1, Satoshi Harada1, Naoto Kuroda2, Kenichi Tanaka3, Kosuke Inoue4, Kyuichi Kadota4, Reiji Haba4, Yoshihiro Nishiyama3, Nobufumi Ueda1, Mikio Sugimoto1.
Abstract
6p21 translocation renal cell carcinoma (RCC) harboring TFEB gene fusion is a newly classified microphthalmia-associated transcription (MiT) factor-family translocation RCC with early onset. We present a case of 78-year-old man with a 6p21 translocation RCC that was diagnosed after partial nephrectomy for an incidental renal tumor on computed tomography (CT). Unenhanced CT showed a 20 mm, mildly low-density mass in the right kidney. Contrast-enhanced CT showed a heterogeneous and prolonged, mild enhancement in the tumor. On magnetic resonance imaging, the tumor showed iso-intensity within the renal parenchyma on T1-weighted-imaging (WI), low intensity on T2WI, and no restricted diffusion with low signal on diffusion-weighted imaging, with no clear tumor pseudocapsule. Fat poor angiomyolipoma and non-clear cell RCC were listed as differential diagnoses. Robot-assisted partial nephrectomy was successfully performed. Fluorescence in situ hybridization study of the resected tumor confirmed TFEB gene break, and the patient was diagnosed with a 6p21 translocation RCC. The patient is doing well without recurrence after 2.5 years of follow-up. Our patient is the oldest patient reported in previous literature. © The Japan Society of Clinical Oncology 2021.Entities:
Keywords: 6p21 translocation; Renal cell carcinoma; TFEB
Year: 2021 PMID: 34221838 PMCID: PMC8206449 DOI: 10.1007/s13691-021-00486-y
Source DB: PubMed Journal: Int Cancer Conf J ISSN: 2192-3183